Dorsey & Whitney Trust’s Stoke Therapeutics STOK Stock Holding History

Dorsey & Whitney Trust’s Portfolio STOK Stock Details STOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$354K	Buy	10,816 +1	+0%	+$32	0.02%	533
2026 Q1	$352K	Hold	10,815	–	–	0.02%	516
2025 Q4	$343K	Hold	10,815	–	–	0.02%	515
2025 Q3	$254K	Hold	10,815	–	–	0.01%	588
2025 Q2	$123K	Hold	10,815	–	–	0.01%	671
2025 Q1	$71.9K	Hold	10,815	–	–	﹤0.01%	659
2024 Q4	$119K	Hold	10,815	–	–	0.01%	667
2024 Q3	$133K	Hold	10,815	–	–	0.01%	653
2024 Q2	$146K	Hold	10,815	–	–	0.01%	610
2024 Q1	$146K	Hold	10,815	–	–	0.01%	612
2023 Q4	$56.9K	Hold	10,815	–	–	﹤0.01%	603
2023 Q3	$42.6K	Buy	+10,815	New	+$71.1K	﹤0.01%	579

Other funds holding STOK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dorsey & Whitney Trust's STOK Position: Q2 2026 in Review

Dorsey & Whitney Trust increased its Stoke Therapeutics (STOK) stake by 0.01% in Q2 2026, buying an estimated $32 and bringing the position to 10,816 shares worth $354K. The position accounts for 0.02% of the portfolio, ranked #533.

Dorsey & Whitney Trust first reported a position in STOK in Q3 2023 and has held it in 12 quarters since. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

Dorsey & Whitney Trust held 10,816 shares of Stoke Therapeutics worth $354K as of Q2 2026.
Dorsey & Whitney Trust bought 1 Stoke Therapeutics share in Q2 2026, an estimated $32.
Stoke Therapeutics made up 0.02% of Dorsey & Whitney Trust's portfolio in Q2 2026, its #533 holding.
Dorsey & Whitney Trust first reported a position in Stoke Therapeutics in Q3 2023 and has held it in 12 quarters since.
197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q2 2026, filed 14 Aug 2026.